Your browser doesn't support javascript.
loading
Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.
Ofuji, Kazuya; Saito, Keigo; Suzuki, Shiro; Shimomura, Manami; Shirakawa, Hirofumi; Nobuoka, Daisuke; Sawada, Yu; Yoshimura, Mayuko; Tsuchiya, Nobuhiro; Takahashi, Mari; Yoshikawa, Toshiaki; Tada, Yoshitaka; Konishi, Masaru; Takahashi, Shinichiro; Gotohda, Naoto; Nakamoto, Yasunari; Nakatsura, Tetsuya.
Afiliação
  • Ofuji K; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Saito K; Second Department of Internal Medicine, University of Fukui, Eiheiji-cho Yoshida-gun, Fukui 910-1193, Japan.
  • Suzuki S; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Shimomura M; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Shirakawa H; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Nobuoka D; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Sawada Y; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Yoshimura M; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Tsuchiya N; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Takahashi M; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Yoshikawa T; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Tada Y; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Konishi M; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Takahashi S; Division of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan.
  • Gotohda N; Division of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan.
  • Nakamoto Y; Division of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan.
  • Nakatsura T; Second Department of Internal Medicine, University of Fukui, Eiheiji-cho Yoshida-gun, Fukui 910-1193, Japan.
Oncotarget ; 8(23): 37835-37844, 2017 Jun 06.
Article em En | MEDLINE | ID: mdl-28035063
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ensaio de Imunoadsorção Enzimática / Imuno-Histoquímica / Carcinoma Hepatocelular / Glipicanas / Neoplasias Hepáticas / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ensaio de Imunoadsorção Enzimática / Imuno-Histoquímica / Carcinoma Hepatocelular / Glipicanas / Neoplasias Hepáticas / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão